Panel 4: What to Expect for Health Policy in the Next Administration?

November 13, 2024
4:20 pm-

5:10 pm

As the next presidential administration takes office the role of health policy discussions may take multiple directions. This panel will feature insights from health policy experts and political strategists as they assess the expected priorities of the incoming administration and the evolving legislative landscape. Panelists will discuss key health care issues that may shape the policy agenda, including potential shifts in regulatory approaches, funding priorities, and strategies for addressing critical topics like health equity, mental health, and innovation in health care. Join us for a forward-looking discussion on the future of health policy under new leadership.

Summit Details

This panel is part of a larger summit event.

November 13, 2024

As the United States approaches the 2024 presidential election, health care remains a pivotal issue for Americans. This symposium will provide an opportunity for us to learn from the outcomes of the election and campaign season about the state of health care and what can be expected in the future....

Speakers

Tanisha Carino, Ph.D.

Chair
Tanisha Carino, Ph.D. is a partner with the Brunswick Group, an advisory firm that helps clients navigate the interconnected financial, political, and social worlds to build trusted relationships with all their stakeholders. She is a corporate affairs and health policy expert who brings over 20 years of experience across multiple healthcare leadership positions in government, private, and non-profit sectors. Prior to joining Brunswick, Tanisha held executive roles as the first Chief Corporate Affairs Officer of Alexion, Executive Director of FasterCures/Milken Institute, led US public policy at GlaxoSmithKline, and was the head of life sciences strategic advisory services for Avalere Health. She began her career as an HIV case worker in Atlanta and a policy researcher in the Medicare program. Dr. Carino is a Fulbright Fellow, has served as a Visiting Fellow for the White House Office of Science and Technology Policy, and earned her doctorate in health policy from Johns Hopkins University. She is associate faculty at the Johns Hopkins Bloomberg School of Public Health, a Visiting Fellow for the Duke-Margolis Health Policy Center, serves on the Board of Directors of Silk Road Medical, One Mind, and is the Vice-Chair of the Alliance for Health Policy.

Dan Mendelson, MPP

Board Member
Dan Mendelson is CEO, Morgan Health, of JPMorgan Chase & Co. He was previously founder and CEO of Avalere Health, a healthcare advisory company based in Washington D.C. Dan also served as operating partner at Welsh Carson, a private equity firm. Before founding Avalere, Dan served as associate director for Health at the Office of Management and Budget in the Clinton White House. Dan currently serves on the board of Champions Oncology (CSBR) and is adjunct professor at the Georgetown University McDonough School of Business. He previously served on the boards of Coventry Healthcare, HMS Holdings, Pharmerica, Partners in Primary Care, Centrexion, and Audacious Inquiry. He holds a bachelor’s from Oberlin College, and a master’s in public policy from the Kennedy School of Government at Harvard University.